Board reviewers flagged a discrepancy in applicant #4's materials: although the proposal discussed the importance of "all MOUD medications," staff later determined the organization could only dispense naltrexone. That limitation prompted concerns that the application had overstated capacity relative to the funding request.
Krista (staff) said reviewers had assumed the applicant could provide multiple MOUD options but subsequent follow-up found the organization "can only dispense naltrexone," a restriction that could have materially affected its score. Board members questioned whether the funding request matched the scope and whether pre-award work (network-building or clearer budgeting) was needed.
Keith (speaker 6) moved to 'pass on' the application (i.e., not approve); Ken (speaker 4) seconded. The motion passed unanimously on a voice vote. Several members asked staff to offer constructive feedback and technical assistance so the organization might resubmit or pursue future funding when its scope and budget are clearer.